Valsartan is an angiotensin II receptor blocker - it blocks the receptor angiotensin II acts on, relaxing blood vessels and lowering blood pressure, without causing the cough that ACE inhibitors do. As a single agent it is an unremarkable member of a large class. What makes it worth its own article is that it is also half of sacubitril-valsartan, a combination that changed heart failure treatment and that carries one firm rule.
Follow the instructions on your label. This guide contains no doses.
Sacubitril-valsartan
Sacubitril inhibits neprilysin, the enzyme that breaks down natriuretic peptides - hormones the heart releases when stretched, which promote sodium and water loss and vessel dilation. Blocking their breakdown enhances a beneficial system.
Neprilysin inhibition alone is not enough, and it has to be paired with blockade of the renin-angiotensin system - hence valsartan.
In its main trial the combination was superior to enalapril in heart failure with reduced ejection fraction, reducing cardiovascular death and hospitalisation - and the trial was stopped early because the benefit was so clear.
It is now a core heart failure treatment, usually replacing the ACE inhibitor or ARB rather than being added.
See heart failure medicines and enalapril.
The washout rule
This is the part that matters most. Combining neprilysin inhibition with an ACE inhibitor causes bradykinin to accumulate from two directions at once, and the result is a substantially increased risk of angioedema.
So when switching from an ACE inhibitor to sacubitril-valsartan, there must be a gap of at least 36 hours with neither drug.
The same applies in reverse.
Switching from an ARB needs no washout, since ARBs do not affect bradykinin.
Do not take your old ACE inhibitor and the new combination together, and make sure you know exactly when to stop one and start the other.
Sacubitril-valsartan must also never be taken alongside a separate ARB - it already contains one, and duplication is a real and avoidable error.
Angioedema
Swelling of the lips, tongue, face or throat is uncommon but can be life-threatening.
Call 999 for any swelling of the mouth or throat or difficulty breathing.
Anyone who has had angioedema on an ACE inhibitor should not be given sacubitril-valsartan without specialist advice, and it is more common in people of Black African and African-Caribbean family origin.
See anaphylaxis.
Valsartan on its own
As a plain ARB, valsartan is used for high blood pressure, after a heart attack, and in heart failure where sacubitril-valsartan is unsuitable.
An ACE inhibitor or ARB is usually first choice for people under 55 who are not of Black African or African-Caribbean family origin, and is added later for those who are.
It is taken once daily, with or without food, though food reduces absorption somewhat - so taking it consistently one way matters more than which.
See why blood pressure needs more than one tablet.
Blood tests are part of the treatment
Kidney function and potassium are checked before starting, one to two weeks after starting or any increase, and periodically thereafter.
A small rise in creatinine after starting is expected and is not a reason to stop. A large rise is different, which is what the test distinguishes.
Valsartan raises potassium, so potassium supplements and salt substitutes containing potassium chloride need checking first - see potassium chloride and spironolactone, which is frequently prescribed alongside in heart failure.
Sick day rules
During illness with vomiting, diarrhoea or fever, an ARB combined with a diuretic and an anti-inflammatory is the recognised route to acute kidney injury.
Ask whether you have sick day rules - see sick day rules and medicines that affect your kidneys.
Pregnancy
Valsartan must not be taken in pregnancy, alone or in combination. ARBs can seriously harm a developing baby, particularly the kidneys.
Do not simply stop - a switch to something suitable is planned. See labetalol.
Side effects
Dizziness, particularly early and after increases - more pronounced with sacubitril-valsartan, which lowers blood pressure more. Get up slowly.
Raised potassium, headache and fatigue.
Anti-inflammatory painkillers reduce the effect and strain the kidneys - see paracetamol.
The contamination recalls
Between 2018 and 2019 a series of valsartan products were recalled worldwide after nitrosamine impurities were found in some manufacturers' supplies.
Those batches were withdrawn and manufacturing standards tightened. Current supplies are not affected.
If you remember the recalls and are uneasy, the honest position is that the risk from the impurity was small and the risk from stopping blood pressure treatment is not - see when a medicine is out of stock.
The Medicines section covers more on how the main families of medicine work - Irbesartan: Protecting Kidneys in Diabetes is closely related to this one.